title: Monitoring cancer through the blood.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
authors.forename: Cloud P
authors.initials: CP
authors.lastname: Paweletz
authors.forename: Pasi A
authors.initials: PA
authors.lastname: Jänne
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004273:DNA, Neoplasm / Q000097:blood*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D004273:DNA, Neoplasm; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride
references.citation: Cancer. 2014 Dec 15;120(24):3896-901
references.pmid: 25103305
references.citation: N Engl J Med. 2013 Mar 28;368(13):1199-209
references.pmid: 23484797
references.citation: Nature. 2013 May 2;497(7447):108-12
references.pmid: 23563269
references.citation: Nature. 2012 Jun 28;486(7404):537-40
references.pmid: 22722843
references.citation: Nat Methods. 2006 Jul;3(7):551-9
references.pmid: 16791214
references.citation: J Thorac Oncol. 2012 Sep;7(9):1369-81
references.pmid: 22858585
references.citation: Nature. 2012 Jun 28;486(7404):532-6
references.pmid: 22722830
references.citation: Nat Med. 2008 Sep;14(9):985-90
references.pmid: 18670422
references.citation: Sci Transl Med. 2012 May 30;4(136):136ra68
references.pmid: 22649089
references.citation: Cancer Discov. 2013 Jun;3(6):658-73
references.pmid: 23729478
references.citation: Clin Cancer Res. 2014 Mar 15;20(6):1698-1705
references.pmid: 24429876
references.citation: Cancer Sci. 2013 Sep;104(9):1198-204
references.pmid: 23721103